The global healthcare and pharmaceutical landscape is rapidly evolving, and clinical trials remain the backbone of drug development and regulatory approval. Accurate, timely, and actionable intelligence on clinical trials is essential for pharmaceutical companies, biotech firms, medtech manufacturers, and investors to make informed decisions regarding research priorities, pipeline management, market entry strategies, and investment opportunities. Market research companies that specialize in clinical trial tracking provide this critical intelligence by offering comprehensive data, analytics, and insights that help organizations navigate complex clinical landscapes, optimize resource allocation, and minimize risk.
In this article, we explore the top 10 market research companies specializing in clinical trials tracking in 2025, evaluated for data depth, analytics capabilities, domain expertise, and their impact on strategic decision-making.
IQVIA is widely recognized as a global leader in healthcare data and analytics. Its clinical trial tracking capabilities leverage an extensive network of data sources, including electronic medical records, claims, trial registries, and patient-level insights. IQVIA’s advanced analytics platforms enable real-time monitoring of ongoing trials, predictive modeling for recruitment and retention, and operational insights to optimize trial execution. For pharmaceutical and biotech companies, IQVIA provides actionable intelligence that supports clinical development strategy, trial feasibility assessments, and risk mitigation across global programs.
IQVIA’s Connected Intelligence framework integrates clinical and commercial data, making it uniquely positioned to provide end-to-end insights from trial design to market launch. This combination of scale, depth, and analytics sophistication makes IQVIA a first-choice partner for enterprises seeking comprehensive clinical trial intelligence.
Informa’s Pharma Intelligence, along with its associated brands, specializes in tracking clinical trial progress, regulatory milestones, and investigator networks. Its platforms provide extensive datasets covering trial phases, recruitment metrics, protocol changes, and regulatory submissions. The company’s intelligence is widely used for competitive benchmarking, pipeline assessment, and trial feasibility evaluations.
Pharma Intelligence’s congress-level coverage ensures clients have early visibility into emerging therapies, trial results, and investigator activity, enabling more informed decisions about collaborations, licensing, and market entry timing. Its combination of data-driven insights and expert analyst interpretation makes it an essential resource for biopharma executives managing complex clinical pipelines.
Clarivate has consolidated several life-science intelligence assets, including Decision Resources Group (DRG), into a single integrated platform. This allows clients to access clinical trial data alongside commercial and payer intelligence, enabling a holistic view of product development and market potential. Clarivate’s trial tracking capabilities include patient enrollment monitoring, site performance analytics, and protocol outcome predictions.
For organizations evaluating pipeline assets, Clarivate’s combination of proprietary databases, expert analyst networks, and workflow tools supports high-stakes decisions such as portfolio prioritization, licensing opportunities, and competitive benchmarking.
DelveInsight specializes in healthcare-focused market research with strong capabilities in clinical trial tracking, particularly for mid-sized biotechs and global pharmaceutical companies. Its analysts provide detailed monitoring of ongoing and upcoming clinical trials across multiple therapy areas, offering insights on trial design, enrollment progress, competitive landscapes, and regulatory milestones.
DelveInsight differentiates itself through its deep therapeutic focus and consultative approach, combining proprietary databases with tailored analysis. This makes it particularly valuable for companies seeking therapy-specific intelligence to guide R&D strategy, identify unmet medical needs, and optimize clinical development pipelines.
Evaluate Ltd, through its Evaluate Pharma platform, offers robust data and analytics focused on drug development and commercialization. Its clinical trial tracking capabilities are integrated with sales forecasts, pipeline probability assessments, and market potential analysis. Evaluate enables investors and corporate strategy teams to assess the commercial impact of ongoing trials and predict outcomes that influence valuations and licensing decisions.
The combination of trial monitoring with financial modeling provides a unique perspective for stakeholders who need to understand both the clinical and commercial implications of emerging therapies.
GlobalData’s Medtrack platform provides an extensive overview of global clinical trials, covering drug pipelines, sponsors, trial phases, and therapeutic areas. Its analytics include recruitment trends, regulatory progress, and competitor trial activity, giving companies a clear view of the clinical landscape.
Medtrack is particularly valuable for monitoring early-stage programs and identifying potential partnership or acquisition opportunities. Its actionable insights help life-science executives make informed decisions about clinical development priorities and strategic collaborations.
Trialtrove, part of Informa’s suite of intelligence tools, offers detailed tracking of clinical trials across therapeutic areas, geographies, and trial phases. Its database allows users to benchmark trial performance, track competitor activity, and monitor key trial milestones. The platform supports decision-making around pipeline prioritization, investigator engagement, and trial site selection.
By combining structured data with expert interpretation, Trialtrove helps organizations streamline clinical development planning and mitigate trial risks, particularly in highly competitive therapy areas.
BioMedTracker, a Clarivate product, focuses on real-time monitoring of clinical trial progress, regulatory milestones, and drug development risks. Its strength lies in tracking and assessing the likelihood of clinical success, providing executives with predictive insights to inform portfolio management and investment decisions.
The platform combines automated data aggregation with analyst-driven risk assessment, offering a concise view of the competitive landscape, trial outcomes, and regulatory events that could impact strategic planning.
Citeline provides comprehensive clinical trial tracking with a focus on operational and strategic insights. Its datasets include trial registration, recruitment status, study endpoints, investigator information, and regulatory approvals. Citeline is widely used by pharmaceutical sponsors, CROs, and investors to optimize clinical trial execution, assess competitive activity, and identify pipeline trends.
The platform’s combination of global coverage, real-time updates, and advanced analytics enables organizations to make informed decisions regarding clinical program prioritization and risk management.
Pharmaprojects, part of Informa Pharma Intelligence, offers a global database of drug development projects and clinical trials. It provides insights into trial design, development timelines, regulatory submissions, and competitor activities. The platform is especially useful for corporate strategy, business development, and investor decision-making, helping organizations anticipate market shifts and identify strategic opportunities.
Pharmaprojects’ integration of clinical, regulatory, and commercial data allows companies to align R&D efforts with market potential and optimize portfolio management.
Choosing the Right Clinical Trial Intelligence Partner
Selecting a clinical trial tracking provider depends on organizational needs, therapeutic focus, and the level of detail required. Large integrated vendors like IQVIA, Informa, and Clarivate offer enterprise-scale data coverage and analytics platforms suitable for global programs. Specialist firms like DelveInsight and Evaluate provide deeper therapeutic expertise, tailored insights, and actionable recommendations for targeted decision-making.
Healthcare executives should consider the following when choosing a provider:
Depth and accuracy of clinical trial data
Timeliness and frequency of updates
Integration with commercial, regulatory, and payer intelligence
Analytic and predictive capabilities
Consultative support and domain expertise
Combining enterprise-scale providers with specialist firms often yields the best insights, balancing broad coverage with therapy-specific intelligence.
Conclusion
In today’s competitive and data-intensive healthcare environment, timely and accurate clinical trial intelligence is essential for strategic decision-making. From IQVIA and Informa’s global data reach to DelveInsight’s therapy-specific expertise, these top 10 market research companies provide the tools and insights needed to navigate clinical development, optimize R&D strategy, and enhance investment decisions.
For pharmaceutical companies, biotech innovators, medtech firms, and investors, partnering with the right clinical trial intelligence provider can accelerate development timelines, mitigate risk, and unlock opportunities in an increasingly complex and competitive market.